Crawford Jeffrey D, Scali Salvatore T, Khan Tabassum, Back Martin R, Cooper Michol, Arnaoutakis Dean K, Berceli Scott A, Upchurch Gilbert J, Huber Thomas S, Giles Kristina A
Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, Gainesville, Fla.
Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, Gainesville, Fla.
J Vasc Surg. 2021 Oct;74(4):1301-1308.e1. doi: 10.1016/j.jvs.2021.03.039. Epub 2021 Apr 19.
Significant physiologic perturbations can occur in patients with chronic mesenteric ischemia (CMI) undergoing open mesenteric bypass (OMB). These events have frequently been attributed to ischemia-reperfusion events and have been directly implicated in the occurrence of multiple organ dysfunction (MOD). Scoring systems (MOD score [MODS] and sequential organ failure assessment [SOFA]) have been derived within the critical care field to provide a composite metric for these pathophysiologic changes. The purpose of the present study was to describe the early pathophysiologic changes that occur after OMB for CMI and determine whether these are predictive of the outcomes.
Patients with CMI who had undergone elective OMB from 2002 to 2018 at a single institution were reviewed. Changes in the hemodynamic, pulmonary, hepatic, renal, and hematologic parameters in the first 96 hours postoperatively were analyzed. The MODSs and SOFA scores were calculated. Cox regression was used to determine the association of the MODSs and SOFA scores with the outcomes.
The use of OMB was analyzed for 72 patients (age, 66 ± 11 years; 68% women; body mass index, 23.8 ± 6 kg/m; 48 ± 34-lb weight loss in 59%). Previous mesenteric stent placement or bypass had been performed in 39% [stenting in 21; bypass in 8; (one patient had both)]. An antegrade configuration (93%) was most common (retrograde configuration, 7%), with revascularization of the superior mesenteric artery/celiac vessels in 85% (superior mesenteric artery only in 15%). Postoperative pathophysiologic and metabolic changes were common, and the mean MODSs and SOFA scores were 3.6 ± 2.4 (range, 1-10) and 4.0 ± 2.7 (range, 1-13), respectively. The median length of stay was 14 days (interquartile range, 9-21). The 30-day mortality was 4% (n = 3) and in-hospital morbidity was 53% (n = 38; gastrointestinal, 25%; infectious, 22%; cardiac, 18%; pulmonary, 18%; renal, 11%). The clinical follow-up period was 16 ± 20 months. The MODSs and SOFA scores correlated linearly with overall mortality (MODS: odds ratio [OR], 1.4; 95% confidence interval [CI], 1.2-1.7; P < .01; SOFA score: OR, 1.4; 95% CI, 1.2-1.7; P < .01 per unit), with a score of ≥5 the inflection point most predictive of mortality (MODS: OR, 3.9; 95% CI, 1.6-9.9; P ≤ .01; SOFA score: OR, 2.8; 95% CI, 1.2-6.6; P = .02). The 1- and 3-year primary bypass patency and freedom from reintervention was 91% ± 5% and 83% ± 7%, respectively, with no association with the MODSs or SOFA scores. The 1- and 3-year survival was 86% ± 4% and 71% ± 6% with significantly worse outcomes for patients with higher MODSs and/or SOFA scores.
Most CMI patients undergoing OMB will experience significant metabolic derangements resulting from sequelae of the ischemia-reperfusion phenomenon postoperatively. These can be objectively assessed in the early postoperative period using simply applied scoring systems to reliably predict the early and long-term outcomes. A derivation of the MODS and/or SOFA score after OMB for CMI can identify the most vulnerable patients at the greatest risk of mortality.
接受开放性肠系膜旁路手术(OMB)的慢性肠系膜缺血(CMI)患者可能会出现显著的生理紊乱。这些事件常被归因于缺血再灌注事件,并直接与多器官功能障碍(MOD)的发生相关。重症监护领域已得出评分系统(MOD评分[MODS]和序贯器官衰竭评估[SOFA]),以提供这些病理生理变化的综合指标。本研究的目的是描述CMI患者接受OMB后早期发生的病理生理变化,并确定这些变化是否可预测预后。
回顾了2002年至2018年在单一机构接受择期OMB的CMI患者。分析术后前96小时内的血流动力学、肺、肝、肾和血液学参数变化。计算MODS和SOFA评分。采用Cox回归确定MODS和SOFA评分与预后的关联。
对72例患者(年龄66±11岁;68%为女性;体重指数23.8±6kg/m²;59%体重减轻48±34磅)的OMB使用情况进行了分析。39%的患者曾进行过肠系膜支架置入或旁路手术(21例置入支架;8例进行过旁路手术;1例两者均有)。顺行构型(93%)最为常见(逆行构型7%),85%的患者肠系膜上动脉/腹腔血管进行了血运重建(仅肠系膜上动脉血运重建15%)。术后病理生理和代谢变化常见,MODS和SOFA评分的平均值分别为3.6±2.4(范围1 - 10)和4.0±2.7(范围1 - 13)。中位住院时间为14天(四分位间距9 - 21天)。30天死亡率为4%(n = 3),住院发病率为53%(n = 38;胃肠道25%;感染22%;心脏18%;肺18%;肾11%)。临床随访期为16±20个月。MODS和SOFA评分与总死亡率呈线性相关(MODS:比值比[OR],1.4;95%置信区间[CI],1.2 - 1.7;P <.01;SOFA评分:OR,1.4;95% CI,1.2 - 1.7;每单位P <.01),评分≥5是最能预测死亡率的转折点(MODS:OR,3.9;95% CI,1.6 - 9.9;P≤.01;SOFA评分:OR,2.8;95% CI,1.2 - 6.6;P =.02)。1年和3年的初次旁路通畅率和无需再次干预率分别为91%±5%和83%±7%,与MODS或SOFA评分无关。1年和3年生存率分别为86%±4%和71%±6%,MODS和/或SOFA评分较高的患者预后明显较差。
大多数接受OMB的CMI患者术后会因缺血再灌注现象的后遗症而出现显著的代谢紊乱。术后早期可使用简单应用的评分系统对这些情况进行客观评估,以可靠地预测早期和长期预后。CMI患者接受OMB后得出的MODS和/或SOFA评分可识别出死亡风险最高的最脆弱患者。